We guarantee to make you the best humanized antibody
We have been delivering humanized antibodies since 1987 and our expertise has been used by the world’s leading pharmaceutical and biotech companies.
The antibody humanization technique we use (CDR grafting) was developed at the MRC giving our scientists unrivalled knowledge about this specialised discipline. We are the only company offering an antibody engineering service who have humanized drugs on the market.
No antibody - no invoice!
Unlike our competitors we continue to applying our proven experience until we reach the optimum humanized antibody candidate. What’s more, we believe in payment by results; we will deliver the best candidate and you don’t have to risk wasting time or money.
We offer other engineering services such as affinity maturation and biophysical characterisation.
Our track record
We have humanized more than 55 antibodies.
Our development work has already delivered three marketed drugs: Tysabri®, Actemra® and Entyvio®.
A further five are in clinical trials (including pembrolizumab (previously known as MK-3475)).
Another two are in preclinical studies.